Today: 21 May 2026
Nvidia stock heads into next week on China H200 headlines as traders brace for Fed
24 January 2026
2 mins read

Nvidia stock heads into next week on China H200 headlines as traders brace for Fed

New York, Jan 24, 2026, 06:58 (EST) — Market closed

  • Nvidia shares closed Friday roughly 1.5% higher following reports that China might be gearing up to place orders for its H200 AI chip
  • Reuters reports CEO Jensen Huang is in Shanghai while Beijing considers allowing the H200 into the country
  • Upcoming milestones include the Fed’s decision on Jan. 28 and Nvidia’s earnings report on Feb. 25

Nvidia shares ended Friday at $187.67, gaining 1.5%, following reports that Chinese authorities have directed several top tech companies in the country to get ready to place orders for Nvidia’s H200 AI chip.

U.S. markets are closed for the weekend, leaving Nvidia’s Monday open to hinge less on chip demand figures and more on policy cues from Beijing. China has been one of the toughest wildcards in the stock’s recent trading.

The H200 headline is crucial since Nvidia’s investors want clear insight into the next phase of data-center demand—and how political moves might stifle it. Even small regulatory changes can swiftly alter near-term forecasts, particularly for a stock that’s essentially a stand-in for AI-related spending.

Nvidia CEO Jensen Huang is in Shanghai on Saturday for the company’s annual celebrations with its China-based staff, Reuters reported. He is also set to visit Beijing, Shenzhen, and Taiwan. Nvidia is still waiting on Beijing’s decision about whether it can sell the H200 chip to Chinese customers—a move Washington has already approved. Chinese authorities have instructed customs agents that the chip is “not permitted” to enter China, though it’s unclear if this amounts to a formal ban or just a temporary hold. Reuters

The H200 ranks among Nvidia’s top-tier “AI accelerators”—chips designed for data centers to train and operate large AI models—and stands as a crucial product for clients expanding computing clusters. That status puts it in the spotlight whenever export restrictions or customs rulings change.

Some investors remain cautious about the China talk. Mizuho trading-desk analyst Jordan Klein noted in a report that “few will assume steady and reliable China [revenue] going forward,” adding the market needs more than headlines before it fully factors China back into forecasts. Morningstar

Looking ahead, traders face what Janus Henderson portfolio manager Julian McManus dubbed a “show-me” phase for richly valued tech stocks, where earnings and guidance must prove that AI investments are translating into sustained revenue. Jason Blackwell, chief investment strategist at Focus Partners Wealth, warned that “significant twists and turns” remain likely this year. Reuters

Chip stocks diverged heading into the weekend, with Intel tumbling roughly 17% on Friday while Nvidia climbed. The gap raised questions about whether Nvidia can maintain momentum based on its own drivers, rather than riding the sector’s overall mood.

Macro factors remain in play. The Federal Reserve’s upcoming policy meeting is set for Jan. 27-28. The rate decision will be announced at 2:00 p.m., followed by Chair Jerome Powell’s remarks at 2:30 p.m. on Jan. 28, per the Fed’s official schedule.

Next week’s big-tech earnings might shift the picture, given that their capital expenditure often fuels demand for Nvidia’s data-center gear. Apple is set to release its fiscal first-quarter results on Thursday, Jan. 29.

Nvidia’s next big date is Feb. 25, when it reports quarterly results. Investors will watch closely for insights on supply issues, shifts in customer orders, and whether political uncertainties are starting to weigh on demand.

There’s a downside risk. Beijing might maintain tight shipment limits despite firms getting the green light to “prepare” orders. The rules could also impose volume caps or slow down delivery. And if U.S.-China tech tensions flare up again, the stock could quickly fall under pressure once more.

As markets reopen Monday, eyes will be on China for any clear signals from Huang’s trip. Traders will also be testing if last week’s rally can hold, with the Fed meeting on Jan. 28 and Nvidia’s earnings on Feb. 25 coming into sharper focus.

Stock Market Today

  • SpaceX IPO Filing Reveals Financials, Musk Could Become First Trillionaire
    May 20, 2026, 7:08 PM EDT. SpaceX filed for an initial public offering (IPO), disclosing its finances and board members for the first time. The company reported $18.7 billion in revenue for 2025, up 33% year-on-year, but posted a net loss of $4.9 billion, reversing a $791 million profit in 2024. First-quarter 2026 losses reached $4.3 billion on $4.7 billion revenue. The IPO, trading as SPCX, may become the largest ever, potentially boosting Elon Musk's wealth to trillionaire status. SpaceX aims to fund its ambitious plans including Starlink satellite network expansion, AI infrastructure, and establishing extraterrestrial colonies.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Disney stock slips into weekend as board flags CEO pick “early 2026” and earnings loom
Previous Story

Disney stock slips into weekend as board flags CEO pick “early 2026” and earnings loom

Exxon stock price: XTO’s Eagle Ford sale push puts XOM in play ahead of key week
Next Story

Exxon stock price: XTO’s Eagle Ford sale push puts XOM in play ahead of key week

Go toTop